Literature DB >> 4685089

The effect of keto-analogues of essential amino acids in severe chronic uremia.

M Walser, A W Coulter, S Dighe, F R Crantz.   

Abstract

Alpha keto-analogues of valine, leucine, isoleucine, methionine, phenylalanine, and (in one instance) tryptophan and histidine, along with the remaining essential amino acids, were administered orally to 10 patients with severe chronic uremia fed a diet low in protein but adequate in calories. Ketoacid dosage varied from 6 to 14 g daily, as sodium or calcium salts. Net nitrogen intake, calculated as intake minus urinary protein nitrogen, averaged 1.8 g/day. The urea space was either estimated or measured with [(14)C]urea and daily changes in the body urea pool were calculated. Urea appearance was measured as the sum of urea excretion and the change in urea pool. If these ketoacids were converted to amino acids and utilized for protein synthesis, a fall in urea nitrogen appearance should occur. In five subjects, ketoacids were given for 15-18 days and then withdrawn. Urea nitrogen appearance increased 1.55 g/day on withdrawing ketoacids, and corrected nitrogen balance decreased by 1.73 g/day. In two other subjects ketoacid administration was followed, on two occasions each, by a period of administration of nine essential amino acids. In three of these four instances, urea appearance rose significantly with amino acids. In four patients studied at high blood urea levels, ketoacid treatment was relatively ineffective; two of these patients responded more favorably when studied again after peritoneal dialysis. One of these improved enough clinically to be managed as an out-patient for short intervals, despite virtual anuria. No accumulation of ketoacids in plasma or urine could be detected, and no toxicity was identified.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4685089      PMCID: PMC302306          DOI: 10.1172/JCI107229

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Utilisation of ketoacid analogues of valine and phenylalanine in health and uraemia.

Authors:  C Giordano; M E Phillips; N G De Santo; C De Pascale; P Fürst; C L Brown; B J Houghton; P Richards
Journal:  Lancet       Date:  1972-01-22       Impact factor: 79.321

2.  Synthesis of phenylalanine and valine by healthy and uraemic men.

Authors:  P Richards; B J Houghton; C L Brown; E Thompson
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

Review 3.  A conspectus of research on amino acid requirements of man.

Authors:  M I Irwin; D M Hegsted
Journal:  J Nutr       Date:  1971-04       Impact factor: 4.798

4.  Maintenance of nitrogen balance in a young woman by substitution of -ketoisovaleric acid for valine.

Authors:  D L Gallina; J M Domínguez; J C Hoschoian; J R Barrio
Journal:  J Nutr       Date:  1971-09       Impact factor: 4.798

5.  Human utilization of urea nitrogen in low calorie diets.

Authors:  D L Gallina; J M Dominguez
Journal:  J Nutr       Date:  1971-08       Impact factor: 4.798

6.  Metabolism of ingested ammonium-15N by premature infants.

Authors:  J F Nicholson
Journal:  Pediatr Res       Date:  1970-09       Impact factor: 3.756

7.  Variation in endogenous nitrogen excretion and dietary nitrogen utilization as determinants of human protein requirement.

Authors:  D H Calloway; S Margen
Journal:  J Nutr       Date:  1971-02       Impact factor: 4.798

8.  Alteration in the urinary excretion rate of amino acids and nitrogen by dietary means in obese and normal human subjects.

Authors:  S A Adibi
Journal:  J Lab Clin Med       Date:  1971-02

9.  Effects of urea loading in patients with far-advanced renal failure.

Authors:  W J Johnson; W W Hagge; R D Wagoner; R P Dinapoli; J W Rosevear
Journal:  Mayo Clin Proc       Date:  1972-01       Impact factor: 7.616

10.  Capacity of human subjects to utilize keto analogues of valine and phenylalanine.

Authors:  D Rudman
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  23 in total

Review 1.  Food intolerance in humans.

Authors:  R H Herman; L Hagler
Journal:  West J Med       Date:  1979-02

Review 2.  Recent advances in the pathogenesis and nutritional treatment of chronic uremia.

Authors:  P Fürst; A Alvestrand; J Bergström
Journal:  Z Ernahrungswiss       Date:  1982-09

3.  Diurnal response in endogenous amino acid oxidation of meal-fed rats.

Authors:  R W Wannemacher; R E Dinterman
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

4.  Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet.

Authors:  D Valle; M Walser; S W Brusilow; M Kaiser-Kupfer
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Leucine. A possible regulator of protein turnover in muscle.

Authors:  M G Buse; S S Reid
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

6.  Chronic vomiting in a case of citrullinaemia detected after treatment by total parenteral nutrition.

Authors:  A Benque; G Bommelaer; G Rozental; P Cales; L Cathelineau; D Pham Dinh; A Ribet
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

7.  The influence of two different essential amino acid/keto analogue preparations on the clinical status of patients with chronic renal failure.

Authors:  E Meisinger; M Strauch
Journal:  Z Ernahrungswiss       Date:  1985-06

8.  Urea metabolism in chronic renal failure.

Authors:  M Walser
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  Branched-chain amino acid nitrogen transfer to alamine in vivo in dogs. Direct isotopic determination with [15N]leucine.

Authors:  E B Galim; K Hruska; D M Bier; D E Matthews; M W Haymond
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

10.  Synthesis of essential amino acids from their alpha-keto analogues by perfused rat liver and muscle.

Authors:  M Walser; P Lund; N B Ruderman; A W Coulter
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.